BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36965256)

  • 21. Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress.
    Martinez-Cifuentes M; Weiss-Lopez B; Santos LS; Araya-Maturana R
    Curr Top Med Chem; 2015; 15(17):1663-72. PubMed ID: 25915614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical Characterization of Curcumin Loaded Chitosan Nanoparticles: Implications in Cervical Cancer.
    Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MMA
    Anticancer Agents Med Chem; 2018; 18(8):1131-1137. PubMed ID: 29651963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells.
    Ghasemi F; Shafiee M; Banikazemi Z; Pourhanifeh MH; Khanbabaei H; Shamshirian A; Amiri Moghadam S; ArefNezhad R; Sahebkar A; Avan A; Mirzaei H
    Pathol Res Pract; 2019 Oct; 215(10):152556. PubMed ID: 31358480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of Curcuma longa and curcumin on reproductive systems.
    Mohebbati R; Anaeigoudari A; Khazdair MR
    Endocr Regul; 2017 Oct; 51(4):220-228. PubMed ID: 29232190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumour effects of metformin and curcumin in human papillomavirus positive and negative head and neck cancer cells.
    Lindsay C; Kostiuk M; Conrad D; O'Connell DA; Harris J; Seikaly H; Biron VL
    Mol Carcinog; 2019 Nov; 58(11):1946-1959. PubMed ID: 31338907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells.
    Singh M; Singh N
    Mol Cell Biochem; 2009 May; 325(1-2):107-19. PubMed ID: 19191010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway.
    Javvadi P; Segan AT; Tuttle SW; Koumenis C
    Mol Pharmacol; 2008 May; 73(5):1491-501. PubMed ID: 18252805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer.
    Madden K; Flowers L; Salani R; Horowitz I; Logan S; Kowalski K; Xie J; Mohammed SI
    Prostaglandins Leukot Essent Fatty Acids; 2009 Jan; 80(1):9-18. PubMed ID: 19058955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects and Mechanisms of Curcumin for the Prevention and Management of Cancers: An Updated Review.
    Yang ZJ; Huang SY; Zhou DD; Xiong RG; Zhao CN; Fang AP; Zhang YJ; Li HB; Zhu HL
    Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 36009200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential anticancer properties and mechanisms of action of curcumin.
    Vallianou NG; Evangelopoulos A; Schizas N; Kazazis C
    Anticancer Res; 2015 Feb; 35(2):645-51. PubMed ID: 25667441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin: updated molecular mechanisms and intervention targets in human lung cancer.
    Ye MX; Li Y; Yin H; Zhang J
    Int J Mol Sci; 2012; 13(3):3959-3978. PubMed ID: 22489192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells.
    Debata PR; Castellanos MR; Fata JE; Baggett S; Rajupet S; Szerszen A; Begum S; Mata A; Murty VV; Opitz LM; Banerjee P
    Gynecol Oncol; 2013 Apr; 129(1):145-53. PubMed ID: 23234806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin-mediated decrease in the expression of nucleolar organizer regions in cervical cancer (HeLa) cells.
    Lewinska A; Adamczyk J; Pajak J; Stoklosa S; Kubis B; Pastuszek P; Slota E; Wnuk M
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Sep; 771():43-52. PubMed ID: 25308441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Fluorescence-Labeled Curcumin Conjugate: Synthesis, Evaluation and Imaging on Human Cell Lines.
    Sheikh S; Sturzu A; Kalbacher H; Nagele T; Weidenmaier C; Horger M; Schwentner C; Ernemann U; Heckl S
    Curr Pharm Des; 2018; 24(16):1821-1826. PubMed ID: 29623828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment.
    Hafez Ghoran S; Calcaterra A; Abbasi M; Taktaz F; Nieselt K; Babaei E
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation, Characterization and In Vitro Biological Evaluation of Novel Curcumin Derivatives as Cytotoxic and Apoptosis-Inducing Agents.
    Arjomandi OK; Almasi S; Hosseinzadeh L; Kavoosi M; Adibi H
    Anticancer Agents Med Chem; 2021; 21(10):1309-1322. PubMed ID: 33006540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Zidan J; Bar Sela G
    Curr Opin Clin Nutr Metab Care; 2011 Nov; 14(6):588-97. PubMed ID: 21986478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Versatile role of curcumin and its derivatives in lung cancer therapy.
    Ashrafizadeh M; Najafi M; Makvandi P; Zarrabi A; Farkhondeh T; Samarghandian S
    J Cell Physiol; 2020 Dec; 235(12):9241-9268. PubMed ID: 32519340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemopreventive and therapeutic effects of curcumin.
    Duvoix A; Blasius R; Delhalle S; Schnekenburger M; Morceau F; Henry E; Dicato M; Diederich M
    Cancer Lett; 2005 Jun; 223(2):181-90. PubMed ID: 15896452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of New Improved Curcumin Derivatives to Multi-targets of Cancer and Inflammation.
    Harikrishnan A; Khanna S; Veena V
    Curr Drug Targets; 2021; 22(5):573-589. PubMed ID: 32753008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.